Canada Filament Health to supply psilocybin for federally-funded psychedelics clinical trial The trial is the first psilocybin study funded by the Canadian Institutes of Health Research (CIHR) Natalia Buendia CalvilloNovember 17, 2022
Canada PharmAla and Mindset enter psilocybin distribution agreement PharmAla will have exclusive rights to resell Mindset's cGMP psilocybin to designated researchers Rowan DunneNovember 16, 2022
Canada PsyCan aims to be ‘go-to’ psychedelics industry organization, receives support from lawmakers The non-profit trade association received a high level of interest from multiple branches of government Rowan DunneNovember 10, 2022
Canada Apex gets Health Canada approval for Veterans take-home psilocybin drug trial Trial will evaluate the efficacy of synthetic psilocybin drug 'APEX-52' for treating vets with PTSD Rowan DunneNovember 4, 2022
Business Pot firm HYTN receives license to produce and sell psilocybin HYTN can possess up to 300gr of psilocybin and sell it in other countries Natalia Buendia CalvilloOctober 17, 2022
Psychedelics Numinus develops psilocybin-infused tea bag for clinical studies The company plans to use mushroom tea to treat patients pending regulatory approvals Rowan DunneOctober 5, 2022
Canada Vancouver mushroom dispensaries continue to operate in legal grey area These relatively new stores remind people about the final days of the cannabis prohibition era in Canada Rowan DunneOctober 3, 2022
Cannabis Psilocybin and cannabis improve breast cancer treatment efficacy: Grace Health New study also suggests that plant-derived medicines can reduce inflammation and improve mental health Rowan DunneSeptember 30, 2022
Psychedelics Psyence sends psilocybin mushrooms to Psilo Pharma in Portugal Shipment marks company's first successful export to Europe and second to date Rowan DunneSeptember 29, 2022
Canada ATMA receives Health Canada approval for new psilocybin trial Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic Rowan DunneSeptember 15, 2022